Resection of the pubic bone as an adjunct to management of primary, recurrent, and metastatic pelvic malignancies.
Patients with locally advanced vulvovaginal carcinomas with pubic bone encroachment or fixation pose a treatment dilemma. The purpose of this study was to evaluate the outcome in 12 patients who have undergone pubic bone resection at the University of Minnesota as part of treatment of locally extensive primary, recurrent, or metastatic vulvovaginal carcinomas. Six patients with primary vulvar carcinomas and six patients with recurrent or metastatic vulvovaginal carcinomas underwent bone resection as part of their surgical therapy. Survival in the primary treatment group was 50%, with no local recurrences. Survival in the recurrent/metastatic disease group was 83%, with a follow-up time of 9 months to 15 years. One vulvar and one groin recurrence have occurred in the recurrent/metastatic group. Pubic bone resection added little to surgical morbidity and gave good functional results. Pubic bone resection, in combination with radical extirpative procedures, is an option for treatment of patients with locally extensive vulvovaginal carcinomas, particularly those with previous radiation therapy.
King
L A
LA
Department of Obstetrics and Gynecology, University of Minnesota Medical School, Minneapolis.
Downey
G O
GO
Savage
J E
JE
Twiggs
L B
LB
Oakley
G J
GJ
Prem
K A
KA
D000230:Adenocarcinoma / Q000401:mortality / Q000601:surgery; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000601:surgery; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D011630:Pubic Bone / Q000601:surgery*; D013997:Time Factors; D014625:Vaginal Neoplasms / Q000401:mortality / Q000601:surgery*; D014846:Vulvar Neoplasms / Q000401:mortality / Q000601:surgery*